According to Inkwood Research, the Global DNA Sequencing Market is estimated to record a CAGR of 17.05% in terms of revenue during the forecasting years of 2021-2028.
“Browse 103 Market Data Tables and 69 Figures spread over 269
Pages, along with an in-depth TOC on the Global DNA Sequencing Market Forecast 2021-2028.”
REQUEST FREE SAMPLE LINK - https://www.inkwoodresearch.com/reports/dna-sequencing-market#request-free-sample
VIEW TABLE OF
CONTENT LINK - https://www.inkwoodresearch.com/reports/dna-sequencing-market#table-of-content
BUY NOW- https://www.inkwoodresearch.com/reports/dna-sequencing-market
DNA sequencing determines the nucleic acid sequence, and
includes technology or method for determining the order of the four bases,
thymine, cytosine, guanine, and adenine. It has gained prominence in life
science research. It is used for sequencing DNA strands and whole genomes, along
with studying DNA-protein interactions.
Research
& Development in DNA Sequencing Propels Market Growth
Research and development activities contribute majorly to
market growth. In the early 1970s, the first DNA sequences were obtained using
challenging methods based on two-dimensional chromatography. The third-generation long-range DNA
sequencing and mapping technologies have revived high-quality genome sequencing.
SMRT (Single-Molecule Real-Time Sequencing) is the first technology of the
third generation. It utilizes the Illumina synthesis approach for DNA
sequencing.
Further, the CSIR (Council of Scientific and Industrial
Research) concluded the six-month exercise of the ‘whole-genome sequence’ of
1008 Indians as a part of the ‘IndiGen’ program. Moreover, machine learning
methods and artificial intelligence are used to tackle genomics problems like
identifying enhancers, positioned nucleosomes, splice sites, promoters, and
annotating genomic sequence elements. Such initiatives are projected to drive
market growth.
To know more about this report, request
a free sample copy.
Biomarker Discovery
is the Major Application
Biomarkers are essential elements that indicate the presence
of diseases. Biomarkers’ intervention makes progress in treating and preventing
complex diseases like diabetes, cardiovascular disease, and cancer, possible.
The genetic variability among patients with the same diseases has made the
clinical application of translational research and molecular biomarkers in
disease treatment uncertain. DNA sequencing can recognize a broad spectrum of
genetic differences and supplement the generation of potent biomarkers in disease
diagnosis and medicine. Declining DNA sequencing costs, brief protocol length,
and low sequencing time, make DNA sequencing a complete tool for biomarker
discovery.
Asia-Pacific:
Fastest-Growing Region
The region has a growing population and developing
healthcare infrastructure. Moreover, applications like animal breeding and
agriculture propel the market demands. Also, the region has an increasing
demand for drug discovery and a rising focus on the biotechnology industry,
along with surging demand for DNA sequencing in the healthcare industry.
Many establishments are adopting innovative technologies and
technologically advanced products. The pandemic has increased the demand for
DNA sequencing. Such aspects drive the strong competitive rivalry in the
market. Siemens Healthineers AG, Illumina Inc, F. Hoffmann-La Roche, Bio-Rad
Laboratories Inc, Agilent Technologies Inc, etc., are among the market’s
prominent players.
About Inkwood
Research
Inkwood Research specializes in syndicated & customized research
reports and consulting services. Market intelligence studies with relevant
fact-based research are customized across industry verticals such as
technology, automotive, chemicals, materials, healthcare, and energy, with an
objective comprehension that acknowledges the business environments. Our
geographical analysis comprises North & South America, CEE, CIS, Middle
East, Europe, Asia, and Africa.
Contact Us
https://www.inkwoodresearch.com
+1 857-302-4704
Related Reports:
Comments
Post a Comment